Skip to content

Based on my review of the GO-CAM model, the protein information, and the relevant literature, I'll now provide a comprehensive assessment of gomodel:60418ffa00001643 - "Deoxyinosine catabolic process (Mouse)".

GO-CAM Model Review: Deoxyinosine catabolic process (Mouse)

Overview

This model represents the deoxyinosine catabolic process in mouse, focusing on the enzymatic pathway that degrades deoxyinosine through a series of oxidation steps leading ultimately to allantoin. The model includes key enzymes like xanthine dehydrogenase/oxidase (Xdh), urate oxidase (Uox), hydroxyisourate hydrolase (Urah), and 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase (Urad), along with purine-nucleoside phosphorylase (Pnp).

Biological Accuracy

The model correctly represents the purine degradation pathway in mice, which differs from humans (humans lack functional urate oxidase). The pathway accurately shows:

  1. Conversion of deoxyinosine to hypoxanthine (mediated by Pnp)
  2. Oxidation of hypoxanthine to xanthine (via Xdh with hypoxanthine dehydrogenase/oxidase activities)
  3. Oxidation of xanthine to uric acid (via Xdh with xanthine dehydrogenase/oxidase activities)
  4. Conversion of uric acid to 5-hydroxyisourate (via Uox)
  5. Further metabolism to allantoin (via Urah and Urad)

This is consistent with established purine metabolism pathways in mice, and the cellular locations (peroxisome for Uox, Urah, and Urad) match UniProt subcellular localization data.

GO-CAM Structure and Connections

The model uses appropriate causal connections between activities, using the "provides input for" (RO:0002413) predicate to show the flow of the pathway. The activities are well-connected in a linear fashion representing the sequential reactions in the pathway.

Each enzyme activity is properly associated with the correct molecular function GO terms: - MGI:97365 (Pnp): GO:0004731 (purine-nucleoside phosphorylase activity) - MGI:98973 (Xdh): Multiple activities including GO:0070674 (hypoxanthine dehydrogenase activity), GO:0070675 (hypoxanthine oxidase activity), GO:0004854 (xanthine dehydrogenase activity), and GO:0004855 (xanthine oxidase activity) - MGI:98907 (Uox): GO:0004846 (urate oxidase activity) - MGI:1916142 (Urah): GO:0033971 (hydroxyisourate hydrolase activity) - MGI:3647519 (Urad): GO:0051997 (2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity)

Evidence Quality

The evidence supporting the model is robust, with multiple types of evidence cited including: - ECO:0000314 (direct assay evidence used in manual assertion) - ECO:0000315 (mutant phenotype evidence used in manual assertion) - ECO:0000266 (sequence orthology evidence used in manual assertion)

Each activity is supported by multiple literature references, including key publications like PMID:30936145, PMID:1590774, PMID:8226898, and PMID:16462750, which I verified discusses the relevant aspects of this pathway.

Adherence to GO-CAM Best Practices

The model adheres to GO-CAM best practices in several ways: 1. Activities are connected in a logical sequence that reflects the actual biological pathway 2. Proper subcellular locations are indicated where relevant (e.g., peroxisome for Uox, Urah, and Urad) 3. Appropriate evidence codes and references are provided for each assertion 4. The model includes output molecules where relevant (e.g., CHEBI:15676 - allantoin as the output of Urad activity)

Suggested Improvements

While the model is generally well-constructed, there are a few potential improvements that could be made:

  1. Molecular Input/Output Specification: Not all activities have explicit input/output entities specified. Adding these would make the model more complete.

  2. Part_of Relations: All activities are appropriately part_of GO:0006149 (deoxyinosine catabolic process), but some are missing occurs_in annotations. For consistency, all activities could specify their subcellular locations.

  3. Xdh Activities: The model correctly represents the multiple activities of Xdh (hypoxanthine dehydrogenase/oxidase and xanthine dehydrogenase/oxidase), but in some cases the same gene product (MGI:MGI:98973) is annotated to the same activity in separate nodes. While this isn't incorrect, it could potentially be streamlined for better clarity.

Conclusion

This GO-CAM model gomodel:60418ffa00001643 is a high-quality representation of the deoxyinosine catabolic process in mouse. It accurately captures the biological pathway, uses appropriate GO terms and relationships, and is well-supported by evidence. The model correctly shows how the sequential activities of multiple enzymes contribute to the degradation of deoxyinosine, culminating in the production of allantoin. Minor improvements could be made in the consistent annotation of cellular locations and molecular inputs/outputs, but overall this is a well-constructed model that meets GO-CAM standards and accurately represents the underlying biology.